AstraZeneca Collaborates with U. of Cambridge, Cancer Research UK on Cancer Projects | GenomeWeb

NEW YORK (GenomeWeb News) – AstraZeneca announced today announced a two-year collaboration with the University of Cambridge and Cancer Research UK on three preclinical and clinical oncology projects, including one focused on gaining a better understanding of the genetic makeup of a patient's cancer through their tumor DNA.

Overall, the collaboration aims to move cancer research forward by studying tumor mutations and new investigational therapies in prostate, pancreatic, and possibly other cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.